Business Description
Scilex Holding Co
NAICS : 325411
SIC : 2834
ISIN : US80880W1062
Description
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -2.08 | |||||
Debt-to-Equity | -0.59 | |||||
Debt-to-EBITDA | -1.1 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -13.61 | |||||
Beneish M-Score | -8.38 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.6 | |||||
3-Year EBITDA Growth Rate | -53.6 | |||||
3-Year EPS without NRI Growth Rate | -52 | |||||
3-Year FCF Growth Rate | 12.1 | |||||
3-Year Book Growth Rate | -17.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 27.35 | |||||
Future 3-5Y Total Revenue Growth Rate | 26.04 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.44 | |||||
9-Day RSI | 42.16 | |||||
14-Day RSI | 48.62 | |||||
6-1 Month Momentum % | -5.13 | |||||
12-1 Month Momentum % | -70.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.15 | |||||
Quick Ratio | 0.14 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 78.03 | |||||
Days Sales Outstanding | 197.92 | |||||
Days Payable | 627.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 9.1 | |||||
Shareholder Yield % | -49.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.14 | |||||
Operating Margin % | -226.01 | |||||
Net Margin % | -229.47 | |||||
FCF Margin % | -7.91 | |||||
ROA % | -111.16 | |||||
ROIC % | -82.82 | |||||
ROC (Joel Greenblatt) % | -3158.04 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.09 | |||||
EV-to-EBIT | -3 | |||||
EV-to-Forward-EBIT | -5.87 | |||||
EV-to-EBITDA | -3.13 | |||||
EV-to-Revenue | 6.79 | |||||
EV-to-Forward-Revenue | 5.42 | |||||
EV-to-FCF | -85.86 | |||||
Earnings Yield (Greenblatt) % | -33.33 | |||||
FCF Yield % | -1.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SCLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Scilex Holding Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 47.045 | ||
EPS (TTM) ($) | -1.31 | ||
Beta | 0 | ||
Volatility % | 158.06 | ||
14-Day RSI | 48.62 | ||
14-Day ATR ($) | 0.166412 | ||
20-Day SMA ($) | 1.84975 | ||
12-1 Month Momentum % | -70.4 | ||
52-Week Range ($) | 0.7316 - 6.55 | ||
Shares Outstanding (Mil) | 121.72 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Scilex Holding Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Scilex Holding Co Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Scilex Holding Co Frequently Asked Questions
What is Scilex Holding Co(SCLX)'s stock price today?
The current price of SCLX is $1.68. The 52 week high of SCLX is $6.55 and 52 week low is $0.73.
When is next earnings date of Scilex Holding Co(SCLX)?
The next earnings date of Scilex Holding Co(SCLX) is 2024-08-09 Est..
Does Scilex Holding Co(SCLX) pay dividends? If so, how much?
Scilex Holding Co(SCLX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |